TCRX vs ZBRA · rev $2.0M vs P/E 28, rev $3.05B
Tscan Therapeutics Inc (TCRX) versus Zebra Technologies Corporation (ZBRA) — a side-by-side from cached financials, not a winner call.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Zebra Technologies Corporation (ZBRA) is a communication equipment company listed on NASDAQ.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
Latest reported ZBRA revenue for 2026-07-04 was $3.05B. Net income was $368.0M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
TCRX currently screens at market cap $62.1M. ZBRA currently screens at market cap $11.10B and trailing P/E 28.1.
Not investment advice. Open the TCRX and ZBRA stock pages for the full models.
Not investment advice.